Skip to content
TECHNOLOGIES FOR VIRAL VECTORS & VACCINES

Overview Technologies

Bring your viral vectors or viral vaccines to the next level with our cutting-edge technologies. From unique vector strains and designer cell lines to advanced packaging and producer cell lines, we provide innovative solutions to ease your development and enhance your production processes. 

IN A NUTSHELL

Stellar Technologies for Viral Vectors and Vaccines

ProBioGen provides all components for successful viral vector and vaccine development, from vector design to expression systems, from process development to GMP manufacturing. We offer a smart molecular and cellular toolbox to create high-performance vectors.

Our expertise in process development and GMP manufacturing ensures customized production for the desired scale, from preclinical material to clinical batches. 

Technologies OVERVIEW KV Icons VV Vaccines
Asset 33
mABs
Asset 36
BsMABs
Asset 30
Complex Recombinant
Proteins
Asset 31
Fusion Proteins
Asset 35
Cytokines
Asset 34
Clotting Factors
WHAT WE OFFER

 

Explore Our Technologies

MVA

MVA Vector Platform MVA.CR19

DirectedLuck Transposase 1600px-1

 Transposase System DirectedLuck®

Lenti.RiGHT 1600px

 Lentivirus Production System Lenti.RiGHT®

GlymaxX ADCC

Designer Cell Line AGE1®

Elevate Your Candidate With The Right CDMO

Explore Related Services for Virals

Asset 5

End-to-End CDMO Services

GMP Production Cell Lines

Producer Cell Line Development

Downstream Process Development-1


Process Development

GMP Manufacturing-2


GMP Manufacturing

5_Quality_Systems

 
Quality Analytics

7_AAV


AAV Production

9_Lentivirus


Lentivirus Production

8_Poxvirus


Poxviruses Production

Explore Related Services

Explore Related Technologies

Related Technologies

GlymaxX ADCC

Genetic Glyco-Engineering / ADCC (GlymaxX®) aaaaaaaaaa
 
 

 

 

DirectedLuck Transposase 1600px-1

DirectedLuck® Transposase with Epigenetic Targeting

Lenti.RiGHT 1600px

Lenti.RiGHT® Packaging and Producer Cell Line aaaaaaa
 
 

 

 

Explore Related Content

Header CDMO

Trends and Requirements in CDMO Projects for Biopharmaceuticals

Blog Post

Blog Image-09-1

Transponsons and Transposases: A Dynamic Duo in Genetic Engineering

Blog Post

COVER Process Intensification Blogpost-16by9 (1)-1

Investing in Efficiency: Benefits of Process Intensification in Upstream Processing

Blog Post

Interim Header Picture

A Success Story on Partnership - the Invisible Superpower in CDMO Projects

Blog Post

Newsletter
Join for ProBioGen News - make sure to be always up-to-date and fully informed with our latest company announcements.